Congratulations to Project PROTECT, recently honored with the 2025 EDSA Catalyst Award for Outstanding Industry Collaboration from the End Drug Shortages Alliance. This award honors a multi-stakeholder partnership that has measurably improved drug access and strengthened supply resilience through cooperation, transparency, and innovation.
Outstanding Industry Collaboration honoring Project PROTECT (Angels for Change, STAQ Pharma, and Children’s Hospital Association) April Giles (Executive Director, EDSA), Terri Lyle Wilson (Vice President of Pharmacy, Children’s Hospital Association), Laura Bray (Chief Change Maker, Angels for Change), Mark Spiecker (President, STAQ Pharma), Jason Chou (EDSA Outgoing Board Chair and Vice President, Pharmacy Services, Ochsner Health), Photo Credit: Elizabeth Le Photography
This award is especially meaningful because it reflects what Project PROTECT was built on from the very beginning: collaboration, ingenuity, and a shared commitment to protecting patients from essential medicine shortages. Together, Angels for Change, STAQ Pharma, and the Children’s Hospital Association designed and launched a model that brings hospitals, advocacy groups, manufacturers, and supply chain experts around one table to strengthen the stability of the drug supply chain.
The End Drug Shortages Alliance (EDSA) launched its inaugural EDSA Catalyst Awards in 2025, celebrating meaningful impact in expanding access to essential medicines for patients.
Reflecting this year’s theme, “Progress Through Partnership,” the 2025 Catalyst Awards honorees exemplify leadership, innovative collaboration, and lifelong dedication to strengthen the resilience of the drug supply chain.
Read the full article below.